ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
4,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,3,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
6,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
8,1,Arrested labour,Failed labour,Maternal complications of labour and delivery,Preg,N
8,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
9,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
10,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
10,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
11,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
12,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
14,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
14,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
14,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
14,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
14,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
15,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
16,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
17,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,2,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
18,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Burns fourth degree,Thermal burns,Injuries by physical agents,Inj&P,Y
19,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
20,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
21,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
21,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
21,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
21,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
22,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
22,2,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
22,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
22,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
25,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
25,3,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
26,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
26,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,3,Dermatitis diaper,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
28,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
28,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
28,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
28,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
30,1,Acne,Acnes,Skin appendage conditions,Skin,N
30,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
31,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
31,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
32,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
32,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
32,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
32,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
33,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
33,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
34,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
37,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
38,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
38,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
38,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
39,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
39,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
40,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
41,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
42,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
43,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
44,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
45,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
46,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
47,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
47,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
47,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
48,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
48,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
48,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
48,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
49,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
50,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
52,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
52,2,Packaging design issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
53,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
53,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
53,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
54,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
54,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
55,2,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
56,1,Anal blister,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
56,2,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
56,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
57,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
58,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
58,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
59,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
60,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
61,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
62,1,Application site scab,Application site reactions,Administration site reactions,Genrl,N
62,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
63,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
64,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
65,1,Anal blister,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
66,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
66,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
67,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
67,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
68,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,2,Dermatitis diaper,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
69,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
69,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
69,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
70,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
70,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
70,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
70,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
71,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
71,3,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
71,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
71,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
72,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
73,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
73,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
74,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
74,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
74,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
74,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,6,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
75,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
76,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
77,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
78,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
78,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
80,2,Nail operation,Nail therapeutic procedures,Skin and subcutaneous tissue therapeutic procedures,Surg,N
80,3,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
80,4,Onychomalacia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
81,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
82,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
82,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
83,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
84,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
85,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
86,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
86,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
88,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
